Plaintiffs in two major wings of the growing litigation over the diabetes drug Invokana are seeking to consolidate the action at the federal and state court level.
Plaintiffs with claims pending in the Philadelphia Court of Common Pleas filed a petition with the court Sept. 23 seeking to consolidate their claims into a mass tort program. The move came less than a week after a New York attorney filed a motion with the U.S. Judicial Panel on Multidistrict Litigation asking that body to consolidate federal claims in the Trenton Division of the U.S. District Court of the District of New Jersey.
